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The	tetrahydroisoquinoline	ring	structure	 is	present	 in	a	 large	
number	of	natural	and	biologically	active	products.	Derivatives	
with	 a	 substituent	 in	 the	 1-position	 are	 particularly	 common	
and	 are	 typically	 prepared	 by	 Pictet–Spengler	 or	 Bischler–
Napieralksi	 reactions.
1




approach	 to	 such	 compounds	 makes	 use	 of	 the	 ability	 to	
deprotonate	 at	 the	 1-position	 of	 the	 tetrahydroisoquinoline	
ring.	 This	 method	 has	 potential	 to	 provide	 access	 to	 a	 large	




	 We	 have	 reported	 that	 an	 efficient	 and	
relatively	 mild	 method	 is	 to	 use	 the	 N-Boc	 derivative	 with	
deprotonation	 by	 using	 n-BuLi.
4,5
	 However	 we	 have	 so	 far	
reported	 only	 a	 few	 examples	with	 the	 parent	 compound	N-




is	 amenable	 to	other	 substituted	 tetrahydroisoquinolines	and	
to	a	variety	of	different	electrophiles,	leading	to	its	application	
to	 the	 syntheses	 of	 the	 alkaloids	 (±)-crispine	 A	 and	 (±)-
dysoxyline.	
	 In	our	earlier	work	we	showed	that	the	Boc	group	in	N-Boc-
tetrahydroisoquinoline	 rotates	 slowly	 at	 –78	 °C.
4
	 As	 the	
lithiation	at	 the	1-position	 is	directed	by	 complexation	of	 the	




is	 faster.	We	wanted	 to	 test	whether	 the	 same	phenomenon	
also	occurs	with	other	derivatives	and	whether	the	lithiation–
substitution	 chemistry	 is	 amenable	 to	 different	 substituted	
tetrahydroisoquinolines.	The	lithiations	of	a	selection	of	N-Boc-






We	 selected	 to	 prepare	 the	 tetrahydroisoquinolines	2–5	 (Fig.	
1).	 These	 compounds	 provide	 a	 range	 of	 electron-donating	
(alkoxy)	and	electron-withdrawing	(chloro	and	trifluoromethyl)	
groups	 on	 the	 tetrahydroisoquinolines	 used	 for	 the	 lithiation	
chemistry.	 For	 syntheses	 of	 compounds	 2–5,	 see	 the	
Supplementary	Information.		
	 The	 lithiation	 of	 tetrahydroisoquinoline	 3	 was	 monitored	
by	in	situ	ReactIR	spectroscopy.	With	1.2	equivalents	of	n-BuLi	
in	 THF	 at	 –78	 °C	 the	 lithiation	 was	 slow.	 However,	 by	
conducting	the	reaction	at	–50	°C	a	rapid	lithiation	took	place	





the	Boc	 group	 (sometimes	 referred	 to	 as	 a	 'complex	 induced	
proximity	 effect'),
6
	 so	 for	 benzylic	 lithiation	 to	 occur	 in	 high	






































min),	 followed	 by	 electrophilic	 quench	 and	 purification	 by	
column	 chromatography,	 the	 substituted	products	6a–c	were	
obtained	with	reasonable	to	good	yields	(Scheme	1).	Lithiation	
occurs	 only	 in	 the	 benzylic	 position,	 as	 judged	 by	
1
H	 NMR	
spectroscopy.	 We	 did	 not	 observe	 any	 other	 substitution	
products.		
	 To	 expand	 the	 range	 of	 substrates	 beyond	 the	 parent	 or	
electron-rich	 tetrahydroisoquinolines	 (compounds	 1–3),	 we	









and	 8a–c	 were	 obtained.	 The	 lithiation–substitution	 was	
selective	 for	 the	1-position,	 indicating	 that	 the	Boc	group	 is	a	
better	directing	group	for	lithiation	than	CF3	or	chlorine.			
	 As	 mentioned	 above,	 in	 the	 lithiation	 step	 the	 n-BuLi	
coordinates	 to	 the	 carbonyl	 oxygen	 atom,
6
	 so	 the	 rate	 of	
lithiation	will	depend	on	the	rate	of	rotation	of	the	Boc	group.	










for	 comparison.	 Variable	 temperature	 NMR	 spectroscopy	 in	



















the	Boc	group	 in	both	compounds	4	 and	1.	 From	this	we	can	
determine,	for	rotation	of	the	Boc	group	in	4,	the	half-life	t1/2	≈	
2	min	 at	 –50	 °C.	 Therefore	 the	 lithiation	 requires	 only	 a	 few	
minutes	at	this	temperature	for	complete	reaction.		
	 By	 using	 1.2	 equivalents	 of	 the	 electrophile	 1,3-
dibromopropane,	 the	 1-substituted	 product	 7d	 was	 formed	
without	any	appreciable	formation	of	the	product	from	double	
electrophilic	 substitution.	 The	 product	 7d	 was	 treated	 with	



















































































































	 We	 were	 interested	 to	 test	 dibromoalkane	 electrophiles	





5).	 By	 using	 0.5	 equivalents	 of	 1,3-dibromopropane	we	were	
able	 to	 prepare	 the	 1,1'-disubstituted	 product	 14	 as	 a	








gave	 the	natural	product	 (±)-crispine	A,	12,	 in	52%	yield	over	
the	 two	 steps.	 This	 chemistry	 therefore	 provides	 a	 short	 and	










to	be	 successful	 in	 these	 alkylation	 reactions,	we	 treated	 the	
tetrahydroisoquinoline	2	with	n-BuLi	in	THF	at	–50	°C	for	4	min	
followed	by	addition	of	propargyl	bromide	or	4-methoxybenzyl	




transformations	 of	 the	 substituted	 products	 are	 possible.	 For	
example,	 treating	 the	 product	 15	 with	 benzyl	 azide	 and	 a	
copper	 catalyst	 gave	 the	 expected	 triazole	 17	 (Scheme	 7).
11
	



























































































	 Finally,	 we	 prepared	 the	 natural	 product	 (±)-dysoxyline	
using	 this	 chemistry.
12
	 The	 tetrahydroisoquinoline	 2	 was	
deprotonated	under	the	standard	conditions	and	then	treated	
with	 the	 bromide	 19	 (Scheme	 9).	 We	 were	 pleased	 that	 this	
gave	a	good	yield	of	the	1-substituted	product	20	despite	the	
potential	 for	 β-elimination.	 Reduction	 of	 this	 product	 with	
LiAlH4	 gave	 (±)-dysoxyline	21.	Hence	 this	 chemistry	 allows	 an	





	 We	 have	 found	 that	 the	 lithiation	 of	 N-Boc-




organolithium	 can	 be	 trapped	 with	 a	 wide	 selection	 of	
different	 electrophiles	 to	 give	 good	 yields	 of	 a	 variety	 of	 1-
substituted	 tetrahydroisoquinoline	 products.	 The	 chemistry	
was	applied	 to	 the	short	syntheses	of	 the	alkaloids	crispine	A	
and	dysoxyline.		
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n-BuLi	 (0.17	 mL,	 0.43	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	3	(100	mg,	0.36	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	iodomethane	(0.08	mL,	1.26	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
























n-BuLi	 (0.17	 mL,	 0.43	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	3	(100	mg,	0.36	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	After	 4	min,	 benzyl	 bromide	 (0.15	mL,	 1.26	mmol)	
was	 added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	

































































































x	 CH),	 7.15–7.04	 (2H,	m,	 2	 x	 CH),	 6.61–6.54	 (2H,	m,	 2	 x	 CH),	
5.94–5.90	 (2H,	 m,	 CH2),	 5.27	 (0.35H,	 t,	 J	 7,	 CH),	 5.13–5.10	
(0.65H,	m,	CH),	4.20–4.12	(0.65H,	m,	CH),	3.81–3.72	(0.35H,	m,	
























and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (92:8),	 to	 give	 the	
carbamate	 6c	 (90	 mg,	 72%)	 as	 an	 oil;	 Rƒ	 0.36	 [petrol–EtOAc	
(90:10)];	 νmax	 (neat)/cm
–1	
2965,	 2930,	 1680,	 1480,	 836,	
1
H	
NMR	 (400	MHz,	 CDCl3,	 rotamers)	 δ	 =	 6.60	 (0.5H,	 s,	 CH),	 6.57	
(0.5H,	 s,	CH),	6.46	 (0.5H,	 s,	 CH),	6.45	 (0.5H,	 s,	CH),	5.92–5.89	
(2H,	m,	CH),	4.83	(0.5H,	br,	CH),	4.67	(0.5H,	br,	CH),	4.18	(0.5H,	








100.6,	 79.7	 &	 79.2,	 49.9	 &	 49.0,	 41.0	 &	 39.8,	 28.9	 &	 28.55,	










n-BuLi	 (0.19	 mL,	 0.49	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	n-butyl	bromide	 (0.12	mL,	1.16	mmol)	
was	 added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	7a	(70	mg,	60%)	as	an	oil;	







CH),	 5.07–5.05	 (0.5H,	 br	 m,	 CH),	 4.25–4.22	 (0.5H,	 br	 m,	 CH),	
4.00–3.97	 (0.5H,	 br	 m,	 CH),	 3.36–3.15	 (1H,	 br	 m,	 CH),	 3.05–
2.93	(2H,	br	m,	2	x	CH),	1.89–1.66	(2H,	br	m,	CH),	1.50	(9H,	s,	t-
Bu),	 1.45–1.29	 (4H,	 m,	 4	 x	 CH),	 0.94–0.89	 (3H,	 m,	 CH3);	
13
C	
NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ	 =	 154.8,	 140.3	 &	 140.1,	
133.3	 &	 133.0,	 131.2	 &	 130.9,	 128.3	 (q,	 J	 28.5	 Hz),	 125.6,	
124.1,	121.7	 (CF3,	 q,	 J	269),	80.0	&	79.7,	54.9	&	54.1,	37.7	&	
36.9,	 36.5	&	35.9,	 29.7	&	28.7,	 28.4,	 25.2	&	25.1,	 22.5,	 14.0;	
HRMS	 (ES)	 Found:	 MNa
+







n-BuLi	 (0.19	 mL,	 0.49	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	 After	 4	min,	 Br(CH2)3Ph	 (0.17	mL,	 1.16	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7b	(84	mg,	61%)	as	an	oil;	






(1H,	 m,	 CH),	 7.30–7.19	 (7H,	 m,	 7	 x	 CH),	 5.30–5.25	 (0.5H,	 m,	
CH),	 5.09–5.00	 (0.5H,	m,	 CH),	 4.30–4.16	 (0.5H,	m,	 CH),	 4.00–
3.97	(0.5H,	m,	CH),	3.26–3.16	(1H.	m,	CH),	3.05–2.92	(2H,	m,	2	
x	 CH),	 2.75–2.67	 (2H,	m,	 2	 x	 CH),	 1.90–1.72	 (4H,	m,	 4	 x	 CH),	
1.51	 (4.5H,	 s,	 t-Bu),	 1.49	 (4.5H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	
CDCl3,	 rotamers)	 δ	 =	 154.8	 &	 154.6,	 142.2	 &	 141.8,	 140.1	 &	
139.8,	133.3	&	133.0,	131.2,	130.9,	128.3,	125.8,	124.3	(CF3,	q,	
J	270),	124.2,	80.1	&	79.8,	54.9	&	53.8,	37.6,	36.4,	36.0,	35.4,	










n-BuLi	 (0.19	 mL,	 0.49	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	4	(100	mg,	0.33	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	Br(CH2)3OPh	(0.17	mL,	1.16	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7c	(90	mg,	64%)	as	an	oil;	





H	NMR	 	 (400	MHz,	 CDCl3)	 δ	 =	 7.52–7.45	 (1H,	m,	 CH),	
7.37–7.25	(4H,	m,	4	x	CH),	6.96–6.90	(3H,	m,	3	x	CH),	5.30–5.27	






(q,	 J	 31),	 125.8,	 124.3,	 121.0	 (CF3,	 q,	 J	 274),	 120.7	 &	 120.6,	
114.5,	80.2	&	79.9,	67.2,	54.6	&	53.7,	37.6	&	36.0,	33.5	&	33.1,	














n-BuLi	 (0.31	 mL,	 0.78	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	4	(200	mg,	0.66	mmol)	in	THF	(3	mL)	at	
–50	 °C.	 After	 4	 min,	 Br(CH2)3Br	 (0.08	 mL,	 0.79	 mmol)	 was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	7d	(180	mg,	68%)	as	an	oil;	






(1H,	 m,	 CH),	 7.35–7.30	 (2H,	 m,	 2	 x	 CH),	 5.26–5.23	 (0.5H,	 m,	
CH),	 5.10–5.08	 (0.5H,	m,	 CH),	 4.33–4.27	 (0.5H,	m,	 CH),	 4.08–
4.06	 (0.5H,	m,	CH),	3.68–3.51	 (2H,	m,	2	x	CH),	3.31–3.15	 (1H,	
m,	CH),	3.00–2.97	(2H,	m,	2	x	CH),	2.05–1.95	(4H,	m,	4	x	CH),	
1.50	 (9H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
154.9	 &	 154.2,	 139.7,	 139.2,	 133.6	 &	 132.6,	 131.3	 &	 130.8,	
125.9	&	125.8,	124.4,	124.3	(q,	J	280),	80.5	&	80.0,	54.1	&	52.9,	
37.6	&	35.9,	35.2	&	34.7,	33.5	&	33.0,	29.8	&	29.2,	28.4,	25.6	&	












n-BuLi	 (0.17	 mL,	 0.44	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	5	(100	mg,	0.37	mmol)	in	THF	(1.5	mL)	
at	–50	°C.	After	4	min,	allyl	bromide	(0.13	mL,	1.3	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	8a	(100	mg,	91%)	as	plates	








4.25–4.22	 (0.6H,	 m,	 CH),	 4.01–3.96	 (0.4H,	 m,	 CH),	 3.30–3.13	
(1H,	 m,	 CH),	 2.93–2.85	 (1H,	 m,	 CH),	 2.73–2.70	 (1H,	 m,	 CH),	




132.9	 &	 132.7,	 131.5,	 130.4	 &	 130.0,	 127.1,	 126.8	 &	 126.7,	
117.7	&	117.3,	80.1	&	79.7,	54.2	&	53.3,	41.3	&	41.0,	38.2	&	

















and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (98:2),	 to	 give	 the	
carbamate	8b	(85	mg,	68%)	as	plates,	m.p.	115–116	°C;	Rƒ	0.36	
[petrol–EtOAc	 (95:5)];	 νmax	 (neat)/cm
–1


























n-BuLi	 (0.17	 mL,	 0.44	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	5	(100	mg,	0.37	mmol)	in	THF	(1.5	mL)	
at	 –50	 °C.	 After	 4	 min,	 n-Bu3SnCl	 (0.36	 mL,	 1.3	 mmol)	 was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(95:5),	to	give	the	carbamate	8b	(120	mg,	57%)	as	an	oil;	





H	 NMR	 	 (400	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
7.00–6.95	 (2H,	 m,	 2	 x	 CH),	 6.85–6.80	 (1H,	 m,	 CH),	 5.34–5.17	
(1H,	m,	 CH),	 4.35–4.25	 (0.5H,	m,	 CH),	 3.85	 (0.5H,	 dt,	 J	12,	 6,	
CH),	3.31	 (0.5H,	ddd,	 J	12,	8,	4,	CH),	3.01–2.85	 (1.5H,	m,	CH),	
2.75–2.65	(1H,	m,	CH),	1.60	(4.5H,	s,	t-Bu),	1.59	(4.5H,	s,	t-Bu),	




















Trifluoroacetic	 acid	 (0.28	 mL,	 3.66	 mmol)	 was	 added	 to	 the	
tetrahydroisoquinoline	 7d	 (400	 mg,	 0.95	 mmol)	 in	 CH2Cl2	 (5	
mL)	at	room	temperature.	After	4	h,	the	solvent	was	removed	
under	 reduced	 pressure.	 Aqueous	 NaOH	 (30	 mL,	 1	 M)	 was	
added	and	the	mixture	was	extracted	with	CH2Cl2	(2	×	10	mL).	
The	 combined	 extracts	 were	 dried	 (MgSO4),	 evaporated,	 and	
the	 residue	was	purified	by	 column	chromatography	on	 silica	
gel,	eluting	with	petrol–EtOAc	(92:8),	to	give	the	amine	9	(210	
mg,	 91%)	 as	 a	 solid;	 m.p.	 76–78	 °C;	 Rf	 0.5	 [petrol–EtOAc	
(80:20)];	 νmax	 (neat)/cm
–1
	 2920,	 2850,	 1470,	 1375;	
1
H	 NMR		




















n-BuLi	 (1.24	 mL,	 2.86	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	 (700	mg,	2.38	mmol)	 in	THF	(10	mL)	
at	 –50	 °C.	 After	 4	 min,	 Br(CH2)4Br	 (0.34	 mL,	 2.86	 mmol)	 was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(98:2),	to	give	the	carbamate	11	(760	mg,	75%)	as	an	oil;	





H	 NMR	 	 (400	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
6.61–6.60	(2H,	m,	2	x	CH),	5.12–5.08	(0.5H,	m,	CH),	4.98–4.95	
(0.5H,	m,	CH),	4.27–4.23	(0.5H,	m,	CH),	4.01–3.98	(0.5,	m,	CH),	






147.4,	 130.2	 &	 129.8,	 126.5	 &	 126.0,	 111.6,	 110.2	 &	 109.9,	
79.9	&	79.5,	56.1,	55.9,	54.2	&	53.4,	38.3	&	36.5,	36.2	&	35.7,	











n-BuLi	 (1.63	 mL,	 4.1	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	°C.	After	4	min,	dibromopropane	(0.41	mL,	4.1	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 to	 give	 the	 crude	 product	 10.	
Trifluoroacetic	 acid	 (0.37	 mL,	 4.9	 mmol)	 was	 added	 to	 this	
crude	product	10	in	CH2Cl2	(15	mL)	and	the	mixture	was	stirred	
at	 room	 temperature.	 After	 4	 h,	 the	 solvent	 was	 evaporated	
and	aqueous	NaOH	(30	mL,	1	M)	was	added.	The	mixture	was	
extracted	with	CH2Cl2	(2	×	20	mL).	The	combined	extracts	were	
dried	 (MgSO4),	 evaporated,	 and	 purified	 by	 column	
chromatography	on	silica,	eluting	with	petrol–EtOAc	(92:8),	to	












Trifluoroacetic	 acid	 (0.1	 mL,	 1.48	 mmol)	 was	 added	 to	 the	




The	 combined	 extracts	 were	 dried	 (MgSO4),	 evaporated,	 and	




























and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (99:1),	 to	 give	 the	
carbamate	 14	 (2.8	 g,	 64%)	 as	 a	 separable	 mixture	 of	
diastereomers	(dr	1:1),	each	as	an	oil:	







(1H,	 m,	 CH),	 4.22–4.19	 (0.85H,	 m,	 CH),	 3.97–3.92	 (1.15H,	 m,	
CH),	3.85	(12H,	br	s,	4	x	CH3),	3.27–3.15	(2H,	m,	CH),	2.86–2.81	
(2H,	m,	CH),	2.63–2.59	(2H,	m,	CH),	1.93–1.72	(4H,	m,	2	x	CH),	




130.1,	 126.4	 &	 126.0,	 111.6	 &	 111.4,	 110.3	 &	 110.0,	 79.7	 &	






649.3433;	 LRMS	 m/z	 (ES)	 649	
(100%).	










1.53	 (2H,	 m,	 CH),	 1.47	 (18H,	 br	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	
CDCl3,	 rotamers)	 δ=	 155.0	 &	 154.8,	 147.5,	 147.3,	 130.5	 &	
130.0,	 126.3	 &	 125.8,	 111.6	 &	 111.4,	 110.3	 &	 109.9,	 79.7	 &	











n-BuLi	 (1.63	 mL,	 4.08	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	°C.	After	4	min,	propargyl	bromide	(0.36	mL,	4.1	mmol)	was	
added.	 The	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	





column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(99:1),	to	give	the	carbamate	15	(0.88	g,	78%)	as	an	oil;	






(1H,	 s,	 CH),	 6.61	 (1H,	 s,	 CH),	 5.27–5.24	 (0.5H,	 m,	 CH),	 5.14	
(0.5H,	t,	J	6,	CH),	4.21–4.18	(0.5H,	m,	CH),	3.97–3.93	(0.5H,	m,	
CH),	3.87	 (6H,	 s,	2	x	CH3),	3.47–3.42	 (0.5H,	m,	CH),	3.31–3.26	
(0.5H,	 m,	 CH),	 2.87–2.71	 (4H,	 m,	 4	 x	 CH),	 2.02–2.00	 (1H,	 m,	
CH),	 1.50	 (9H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	 rotamers,	
alkyne	 C	 atoms	 could	 not	 be	 observed)	 δ	 =	 154.6	 &	 154.4,	
147.9	&	147.8,	147.3,	127.8	&	127.6,	126.7	&	126.5,	111.4	&	











n-BuLi	 (1.6	 mL,	 4.1	 mmol,	 2.5	 M	 in	 hexane)	 was	 added	 to	
tetrahydroisoquinoline	2	(1.0	g,	3.4	mmol)	in	THF	(14	mL)	at	–
50	 °C.	 After	 4	 min,	 4-methoxybenzyl	 chloride	 (0.6	 mL,	 4.1	
mmol)	was	added.	The	mixture	was	allowed	to	warm	to	room	
temperature	 over	 16	 h	 and	 MeOH	 (1	 mL)	 was	 added.	 The	
solvent	 was	 evaporated	 and	 the	 residue	 was	 purified	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–
EtOAc	(92:8),	to	give	the	carbamate	16	(980	mg,	70%)	as	an	oil;	





H	 NMR	 	 (400	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
7.05–7.02	 (2H,	 m,	 2	 x	 CH),	 6.85–6.80	 (2H,	 m,	 2	 x	 CH),	 6.63	






1.35	 (6H,	 s,	 	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	 rotamers)	 δ	 =	
158.3	&	158.1,	154.6	&	154.5,	147.6	&	147.5,	146.9	&	146.7,	
130.8	&	130.6,	130.7	&	130.5,	128.8	&	128.6,	126.6	&	126.3,	
113.7	 &	 113.5,	 111.3	 &	 111.0,	 110.7	 &	 110.3,	 79.5	 &	 79.4,	
56.5,	55.9	&	55.8,	55.7	&	55.6,	55.3	&	55.2,	42.0	&	41.8,	39.3	&	










The	 tetrahydroisoquinoline	 15	 (500	 mg,	 1.5	 mmol),	 benzyl	
azide	 (200	 mg,	 1.8	 mmol),	 CuSO4·H2O	 (300	 mg,	 1.8	 mmol),	
ascorbic	 acid	 (300	 mg,	 1.8	 mmol),	 L-proline	 (200	 mg,	 1.81	
mmol),	and	Na2CO3	 (100	mg,	1.8	mmol)	were	heated	at	65	°C	
in	 DMSO–water	 (10	 mL,	 9:1).	 After	 18	 h,	 the	 mixture	 was	
cooled	to	room	temperature	and	saturated	aqueous	NH4Cl	(30	
mL)	was	added.	The	precipitate	was	filtered	and	washed	with	
water	 (100	 mL).	 The	 combined	 extracts	 were	 dried	 (MgSO4),	
evaporated,	and	purified	by	column	chromatography	on	silica	









3.91	 (0.5H,	 m,	 CH),	 3.85	 (3H,	 s,	 OCH3),	 3.81	 (1.7H,	 s,	 OCH3),	
3.76	 (1.3H,	 s,	OCH3),	 3.21–3.02	 (2.5H,	m,	 CH),	 3.02–2.76	 (1H,	
m,	CH),	 2.62–2.57	 (1H,	m,	CH),	 1.99–1.84	 (0.5H,	m,	CH),	 1.38	
(3H,	 s,	 t-Bu),	 1.26	 (6H,	 s,	 t-Bu);	
13
C	 NMR	 (100	 MHz,	 CDCl3,	
rotamers)	 δ	 =	 154.8	 &	 154.4,	 147.8,	 147.4,	 145.2	 &	 144.8,	
135.0	 &	 134.6,	 129.1,	 128.8,	 128.7	 &	 128.6,	 128.0	 &	 127.9,	
126.2,	121.9,	111.4,	109.9,	79.7	&	79.5,	56.0	&	55.9,	54.4,	54.0,	










The	 carbamate	 6b	 (100	 mg,	 0.24	 mmol)	 in	 THF	 (1	 mL)	 was	
added	to	a	suspension	of	LiAlH4	(500	mg,	1.2	mmol)	in	THF	(5	
mL)	 at	 0	 °C	 under	 nitrogen.	 The	mixture	was	 stirred	 at	 room	
temperature	for	1	h	then	was	heated	under	reflux.	After	16	h,	
the	 mixture	 was	 allowed	 to	 cool	 to	 room	 temperature.	
Aqueous	 NaOH	 (5	 mL,	 1	 M)	 was	 added	 dropwise.	 The	 solids	
were	 removed	 by	 filtration	 though	 Celite	 and	 were	 washed	
with	 CH2Cl2–MeOH	 (9:1).	 The	 filtrate	 was	 evaporated	 and	
purified	 by	 column	 chromatography	 on	 silica,	 eluting	 with	
CH2Cl2–MeOH	(95:5),	to	give	the	amine	18	(50	mg,	69%)	as	an	









2.59–2.53	 (1H,	m,	CH),	 2.49	 (3H,	 s,	 CH3);	
13
C	NMR	 (100	MHz,	
















and	 the	 residue	 was	 purified	 by	 column	 chromatography	 on	
silica	 gel,	 eluting	 with	 petrol–EtOAc	 (92:8),	 to	 give	 the	
carbamate	 20	 (1.08	 g,	 72%)	 as	 an	 oil;	 Rf	 0.12	 [petrol–EtOAc	
(80:20)];	 νmax	 (neat)/cm
–1




(2H,	 s,	 OCH2O),	 5.18–5.01	 (1H,	 m,	 CH),	 4.28–4.26	 (0.5H,	 m,	






&	 125.9,	 120.9,	 111.6,	 110.2	 &	 109.9,	 108.7	 &	 108.1,	 100.7,	
79.9	&	79.4,	56.0	&	55.9,	54.4	&	53.6,	39.1	&	38.7,	36.9,	32.7,	














0.24	 mmol)	 and	 LiAlH4	 (500	 mg,	 1.2	 mmol)	 gave,	 after	
purification	by	column	chromatography	on	silica,	eluting	with	
Et2O–petrol	(97.5:2.5),	(±)-dysoxyline	21	(60	mg,	75%)	as	an	oil;	






CH),	6.66–6.62	 (1H,	m,	CH),	6.58	 (1H,	s,	CH),	6.55	 (1H,	s,	CH),	
5.92	(2H,	s,	OCH2O),	3.85	(3H,	s,	OCH3),	3.82	(3H,	s,	OCH3),	3.42	
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